KENNETH WILSON: Open Payments
NPI 1780747220 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,486 in 52 payments from 11 companies in 2025. Trend: 2023 $1,120 · 2024 $1,353 · 2025 $1,486
Food & beverage: $1,486
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $290 |
| ABBVIE INC. | 22 | $282 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $237 |
| E.R. Squibb & Sons, L.L.C. | 5 | $213 |
| Teva Pharmaceuticals USA, Inc. | 4 | $152 |
| Axsome Therapeutics, Inc. | 2 | $129 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, LYBALVI, COBENFY, AUSTEDO XR, Auvelity, ARISTADA, INGREZZA.
Industry payments across NY — which companies pay providers there.
